WUXI BIOLOGICS (CAYMAN) INCWUXI BIOLOGICS (CAYMAN) INCWUXI BIOLOGICS (CAYMAN) INC

WUXI BIOLOGICS (CAYMAN) INC

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
1.01MXN
Revenue estimate
‪18.89 B‬MXN
Market capitalization
‪119.82 B‬MXN
‪8.17 B‬MXN
‪40.93 B‬MXN
‪3.07 B‬
Beta (1Y)
1.39

About WUXI BIOLOGICS (CAYMAN) INC

CEO
Zhi Sheng Chen
Headquarters
Wuxi
Employees (FY)
‪12.74 K‬
Founded
2014
ISIN
KYG970081173
FIGI
BBG00YG35MQ9
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. Its products include antibody drugs, biological medicines, and other tablets, as well as provides research material generation, sterility assurance programs, clinical trials, and translational oncology research services. The company was founded on February 27, 2014 and is headquartered in Wuxi, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 2269/N is 62.53 MXN — it has decreased by 34.04% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange WUXI BIOLOGICS (CAYMAN) INC stocks are traded under the ticker 2269/N.
WUXI BIOLOGICS (CAYMAN) INC is going to release the next earnings report on Aug 19, 2024. Keep track of upcoming events with our Earnings Calendar.
2269/N stock is 51.61% volatile and has beta coefficient of 1.39. Check out the list of the most volatile stocks — is WUXI BIOLOGICS (CAYMAN) INC there?
2269/N earnings for the last quarter are 1.54 MXN per share, whereas the estimation was 1.30 MXN resulting in a 18.18% surprise. The estimated earnings for the next quarter are 0.60 MXN per share. See more details about WUXI BIOLOGICS (CAYMAN) INC earnings.
WUXI BIOLOGICS (CAYMAN) INC revenue for the last quarter amounts to ‪20.07 B‬ MXN despite the estimated figure of ‪19.24 B‬ MXN. In the next quarter revenue is expected to reach ‪20.07 B‬ MXN.
Yes, you can track WUXI BIOLOGICS (CAYMAN) INC financials in yearly and quarterly reports right on TradingView.
2269/N net income for the last quarter is ‪2.66 B‬ MXN, while the quarter before that showed ‪5.61 B‬ MXN of net income which accounts for −52.51% change. Track more WUXI BIOLOGICS (CAYMAN) INC financial stats to get the full picture.
Today WUXI BIOLOGICS (CAYMAN) INC has the market capitalization of ‪119.82 B‬, it has increased by 0.57% over the last week.
No, 2269/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2269/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WUXI BIOLOGICS (CAYMAN) INC stock right from TradingView charts — choose your broker and connect to your account.
2269/N reached its all-time high on Jun 30, 2021 with the price of 369.86 MXN, and its all-time low was 62.53 MXN and was reached on Dec 20, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has ‪12.74 K‬ employees. See our rating of the largest employees — is WUXI BIOLOGICS (CAYMAN) INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So WUXI BIOLOGICS (CAYMAN) INC technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating WUXI BIOLOGICS (CAYMAN) INC stock shows the strong sell signal. See more of WUXI BIOLOGICS (CAYMAN) INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on WUXI BIOLOGICS (CAYMAN) INC future price: according to them, 2269/N price has a max estimate of 116.29 MXN and a min estimate of 26.13 MXN. Read a more detailed WUXI BIOLOGICS (CAYMAN) INC forecast: see what analysts think of WUXI BIOLOGICS (CAYMAN) INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WUXI BIOLOGICS (CAYMAN) INC EBITDA is ‪12.82 B‬ MXN, and current EBITDA margin is 31.22%. See more stats in WUXI BIOLOGICS (CAYMAN) INC financial statements.